Insider Transactions in Q2 2022 at Avantor, Inc. (AVTR)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 23
2022
|
Frederic Vanderhaegen EVP, Americas and Europe |
SELL
Open market or private sale
|
Direct |
39,000
-23.53%
|
$1,209,000
$31.61 P/Share
|
|
May 20
2022
|
Gerard Brophy EVP, Biopharma Production |
SELL
Open market or private sale
|
Direct |
19,603
-16.82%
|
$607,693
$31.27 P/Share
|
|
May 17
2022
|
Gerard Brophy EVP, Biopharma Production |
SELL
Payment of exercise price or tax liability
|
Direct |
19,683
-14.45%
|
$610,173
$31.33 P/Share
|
|
May 17
2022
|
Michael Stubblefield President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
108,700
-8.37%
|
$3,369,700
$31.33 P/Share
|
|
May 17
2022
|
Christophe Couturier EVP, AMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
16,212
-14.15%
|
$502,572
$31.33 P/Share
|
|
May 17
2022
|
Thomas A Szlosek EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,261
-14.23%
|
$721,091
$31.33 P/Share
|
|
May 17
2022
|
Justin Miller EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
12,935
-14.02%
|
$400,985
$31.33 P/Share
|
|
May 17
2022
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
573
-3.13%
|
$17,763
$31.33 P/Share
|
|
May 17
2022
|
Frederic Vanderhaegen EVP, Americas and Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
2,210
-1.32%
|
$68,510
$31.33 P/Share
|
|
May 12
2022
|
Gregory L Summe Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,693
+22.75%
|
-
|
|
May 12
2022
|
Lan Kang Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,693
+35.94%
|
-
|
|
May 12
2022
|
Jonathan M Peacock Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,693
+3.66%
|
-
|
|
May 12
2022
|
Juan Andres Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,693
+18.19%
|
-
|
|
May 12
2022
|
John Carethers Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,693
+38.99%
|
-
|
|
May 12
2022
|
Joseph R Massaro Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,693
+43.61%
|
-
|
|
May 12
2022
|
Mala Murthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,693
+43.13%
|
-
|
|
May 12
2022
|
Matthew S. Holt Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,693
+45.84%
|
-
|
|
May 12
2022
|
Christi Shaw Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,693
+20.19%
|
-
|
|
May 12
2022
|
Michael Severino Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,693
+21.01%
|
-
|
|
May 04
2022
|
Michael Stubblefield President & CEO |
BUY
Bona fide gift
|
Indirect |
14,500
+3.38%
|
-
|
|
May 04
2022
|
Michael Stubblefield President & CEO |
SELL
Bona fide gift
|
Direct |
14,500
-1.1%
|
-
|
|
Apr 05
2022
|
Christophe Couturier EVP, AMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
568
-0.49%
|
$17,608
$31.62 P/Share
|
|
Apr 01
2022
|
John Carethers Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,215
+24.32%
|
-
|
|
Apr 01
2022
|
Michael Severino Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,215
+6.17%
|
-
|
|
Apr 01
2022
|
Gregory L Summe Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,215
+7.04%
|
-
|
|
Apr 01
2022
|
Mala Murthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,215
+36.31%
|
-
|
|
Apr 01
2022
|
Rajiv Gupta Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,215
+0.16%
|
-
|
|
Apr 01
2022
|
Lan Kang Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,215
+18.83%
|
-
|
|
Apr 01
2022
|
Jonathan M Peacock Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,215
+0.71%
|
-
|
|
Apr 01
2022
|
Christi Shaw Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,215
+5.79%
|
-
|
|
Apr 01
2022
|
Juan Andres Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,215
+4.94%
|
-
|
|
Apr 01
2022
|
Joseph R Massaro Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,215
+38.27%
|
-
|
|
Apr 01
2022
|
Matthew S. Holt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,215
+50.0%
|
-
|